Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thienorphine Hydrochloride Tablets for Relapse Prevention After Opioid Dependence Detoxification
NCT03656120Phase 2Unknown
- Start
- Aug 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of thienorphine in opioid use disorder (OUD) (3 arms). Primary endpoint: Days of retention in outpatient treatment at 12 weeks. Status: unknown.
02
Drugs
thienorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03656120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03656120.